Drug Shortage Report for DIHYDROERGOTAMINE (DHE), 1MG/ML

Last updated on 2022-01-20 History
Report ID 147980
Drug Identification Number 00027243
Brand name DIHYDROERGOTAMINE (DHE), 1MG/ML
Common or Proper name DIHYDROERGOTAMINE MESYLATE INJECTION USP (DHE)
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) DIHYDROERGOTAMINE MESYLATE
Strength(s) 1MG
Dosage form(s) LIQUID
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 5 AMPOULES
ATC code N02CA
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-11-01
Actual start date
Estimated end date 2022-01-17
Actual end date 2022-01-19
Shortage status Resolved
Updated date 2022-01-20
Company comments One-time allocation of remaining stock will be available at McKesson on November 1st.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-10-26 English Compare
v2 2021-10-26 French Compare
v3 2021-11-02 English Compare
v4 2021-12-16 English Compare
v5 2021-12-16 French Compare
v6 2022-01-07 English Compare
v7 2022-01-07 French Compare
v8 2022-01-19 English Compare
v9 2022-01-19 French Compare
v10 2022-01-20 English Compare

Showing 1 to 10 of 10